Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,672 | 470 | 96.8% |
| Education | $289.95 | 13 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,265 | 112 | $0 (2024) |
| Novo Nordisk Inc | $661.01 | 32 | $0 (2024) |
| PFIZER INC. | $398.71 | 23 | $0 (2024) |
| ABBVIE INC. | $359.56 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $326.91 | 18 | $0 (2023) |
| EISAI INC. | $321.17 | 20 | $0 (2022) |
| Amgen Inc. | $302.50 | 15 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $289.69 | 16 | $0 (2017) |
| Lilly USA, LLC | $235.17 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $224.14 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,247 | 53 | AstraZeneca Pharmaceuticals LP ($277.35) |
| 2023 | $1,238 | 63 | AstraZeneca Pharmaceuticals LP ($348.03) |
| 2022 | $1,361 | 72 | AstraZeneca Pharmaceuticals LP ($254.54) |
| 2021 | $1,446 | 83 | AstraZeneca Pharmaceuticals LP ($375.89) |
| 2020 | $701.81 | 42 | AstraZeneca Pharmaceuticals LP ($252.89) |
| 2019 | $905.24 | 49 | AstraZeneca Pharmaceuticals LP ($276.83) |
| 2018 | $960.92 | 54 | AstraZeneca Pharmaceuticals LP ($317.54) |
| 2017 | $1,103 | 67 | Valeant Pharmaceuticals North America LLC ($289.69) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Endocrinology | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/16/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $54.13 | General |
| Category: Insulin Pump | ||||||
| 10/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Endocrinology | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Endocrinology | ||||||
| 08/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.72 | General |
| 08/19/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Hematology | ||||||
| 08/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,601 | 9,880 | $1.3M | $562,930 |
| 2022 | 33 | 2,496 | 10,580 | $1.4M | $660,096 |
| 2021 | 26 | 1,875 | 8,767 | $1.2M | $590,357 |
| 2020 | 24 | 1,707 | 7,124 | $834,766 | $365,522 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 443 | 2,573 | $385,935 | $215,557 | 55.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 397 | 1,345 | $294,774 | $126,668 | 43.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 181 | 334 | $65,130 | $37,793 | 58.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 139 | 1,030 | $101,970 | $36,168 | 35.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 139 | 1,025 | $101,475 | $36,161 | 35.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 139 | 1,049 | $156,301 | $29,962 | 19.2% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 227 | 489 | $48,900 | $24,859 | 50.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 97 | 196 | $28,420 | $9,588 | 33.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 121 | 184 | $27,600 | $9,252 | 33.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 78 | 125 | $21,875 | $8,636 | 39.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 39 | 44 | $17,556 | $7,924 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $12,459 | $7,786 | 62.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 25 | 25 | $4,375 | $3,270 | 74.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 78 | 200 | $6,000 | $3,244 | 54.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 100 | 198 | $4,950 | $1,902 | 38.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 52 | 58 | $1,740 | $939.60 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $660.00 | $646.80 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 24 | 24 | $720.00 | $525.60 | 73.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 60 | 586 | $4,395 | $440.48 | 10.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $425.00 | $416.50 | 98.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 24 | 25 | $3,750 | $344.29 | 9.2% |
| 90471 | Administration of vaccine | Office | 2023 | 21 | 21 | $525.00 | $296.39 | 56.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,518 | $227.92 | 15.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 35 | $875.00 | $116.24 | 13.3% |
| J0698 | Injection, cefotaxime sodium, per gm | Office | 2023 | 17 | 23 | $230.00 | $94.02 | 40.9% |
About Dr. Barry Liberoni, MD
Dr. Barry Liberoni, MD is a Internal Medicine healthcare provider based in Bay City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861470361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Liberoni, MD has received a total of $8,962 in payments from pharmaceutical and medical device companies, with $1,247 received in 2024. These payments were reported across 483 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($8,672).
As a Medicare-enrolled provider, Liberoni has provided services to 8,679 Medicare beneficiaries, totaling 36,351 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bay City, TX
- Active Since 01/04/2006
- Last Updated 10/24/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861470361
Products in Payments
- FARXIGA (Drug) $1,949
- XIFAXAN (Drug) $378.29
- Dayvigo (Drug) $304.50
- JARDIANCE (Drug) $253.01
- NURTEC ODT (Drug) $243.01
- Trintellix (Drug) $206.91
- RELISTOR (Drug) $204.17
- BREZTRI (Drug) $194.58
- SUNOSI (Drug) $183.16
- ELIQUIS (Drug) $164.42
- VRAYLAR (Drug) $161.84
- ENTRESTO (Drug) $158.17
- Ozempic (Drug) $154.56
- Otezla (Drug) $148.13
- Kerendia (Drug) $147.38
- Korlym (Drug) $144.09
- Tresiba (Drug) $139.88
- LINZESS (Drug) $126.80
- Sunosi (Drug) $115.30
- EUCRISA (Drug) $112.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bay City
Jeffrey Potts, Md, MD
Internal Medicine — Payments: $120,027
Dr. Gassan Alaouie, Do, DO
Internal Medicine — Payments: $16,907
Mohamed Ali, M.d, M.D
Internal Medicine — Payments: $7,432
Dr. Praveen Kamaraju, M.d, M.D
Internal Medicine — Payments: $7,427
Dr. Naeem Ahmed, M.d, M.D
Internal Medicine — Payments: $6,432
Dr. Lakshmi Arekapudi, M.d, M.D
Internal Medicine — Payments: $6,196